These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18436267)

  • 1. The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole.
    Hu XQ; Lovinger DM
    Neuropharmacology; 2008 Jun; 54(8):1153-65. PubMed ID: 18436267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
    Hu XQ; Lovinger DM
    J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of L293 in transmembrane two of the mouse 5-hydroxytryptamine3A receptor alter gating and alcohol modulatory actions.
    Hu XQ; Hayrapetyan V; Gadhiya JJ; Rhubottom HE; Lovinger DM; Machu TK
    Br J Pharmacol; 2006 May; 148(1):88-101. PubMed ID: 16520747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
    Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
    Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine 222 in the pre-transmembrane domain 1 of 5-HT3A receptors links agonist binding to channel gating.
    Hu XQ; Zhang L; Stewart RR; Weight FF
    J Biol Chem; 2003 Nov; 278(47):46583-9. PubMed ID: 12970351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors.
    Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the Val291 residue within the transmembrane domain 2 in diltiazem- and TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester]-mediated 5-hydroxytryptamine type 3A receptor regulations.
    Lee BH; Choi SH; Pyo MK; Shin TJ; Hwang SH; Kim BR; Lee JH; Rhim H; Kim HC; Nah SY
    Biol Pharm Bull; 2009 May; 32(5):861-7. PubMed ID: 19420755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational Changes in the 5-HT
    Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol enhances 5-hydroxytryptamine type 3A receptor-mediated ion currents: the role of arginine 222 residue in pre-transmembrane domain I.
    Lee BH; Hwang SH; Choi SH; Shin TJ; Kang J; Lee SM; Nah SY
    Biol Pharm Bull; 2011; 34(4):523-7. PubMed ID: 21467640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
    Solt K; Stevens RJ; Davies PA; Raines DE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modular design of Cys-loop ligand-gated ion channels: functional 5-HT3 and GABA rho1 receptors lacking the large cytoplasmic M3M4 loop.
    Jansen M; Bali M; Akabas MH
    J Gen Physiol; 2008 Feb; 131(2):137-46. PubMed ID: 18227272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor.
    Hu XQ; Peoples RW
    J Biol Chem; 2008 Mar; 283(11):6826-31. PubMed ID: 18187416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor.
    Koo BN; Kim MK; Yang J; Min KT
    Neurosci Lett; 2009 Nov; 465(2):147-50. PubMed ID: 19765401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol stabilizes the open state of single 5-hydroxytryptamine(3A)(QDA) receptors.
    Feinberg-Zadek PL; Davies PA
    J Pharmacol Exp Ther; 2010 Jun; 333(3):896-902. PubMed ID: 20200118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine 246 of the pretransmembrane domain 1 region alters 2,2,2-trichloroethanol action in the 5-hydroxytryptamine3A receptor.
    Hu XQ; Peoples RW
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1011-8. PubMed ID: 18094321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
    Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
    Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.
    Trattnig SM; Harpsøe K; Thygesen SB; Rahr LM; Ahring PK; Balle T; Jensen AA
    J Biol Chem; 2012 Jul; 287(30):25241-54. PubMed ID: 22589534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subunit-dependent modulation of the 5-hydroxytryptamine type 3 receptor open-close equilibrium by n-alcohols.
    Rüsch D; Musset B; Wulf H; Schuster A; Raines DE
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1069-74. PubMed ID: 17360702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length and amino acid sequence of peptides substituted for the 5-HT3A receptor M3M4 loop may affect channel expression and desensitization.
    McKinnon NK; Bali M; Akabas MH
    PLoS One; 2012; 7(4):e35563. PubMed ID: 22539982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ginsenoside interaction sites in 5-HT3A receptors.
    Lee BH; Lee JH; Lee SM; Jeong SM; Yoon IS; Lee JH; Choi SH; Pyo MK; Rhim H; Kim HC; Jang CG; Lee BC; Park CS; Nah SY
    Neuropharmacology; 2007 Mar; 52(4):1139-50. PubMed ID: 17257631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.